NT PHARMA-NEW: VOLUNTARY ANNOUNCEMENT MEMORANDUM OF UNDERSTANDING ON POSSIBLE COOPERATION
NT PHARMA-NEW: TERMINATION OF THE VERY SUBSTANTIAL ACQUISITION IN RELATION TO THE LICENSING OF COMMERCIALISATION RIGHT AND CHANGE IN USE OF PROCEEDS FROM THE PLACING
NT PHARMA: SUPPLEMENTAL ANNOUNCEMENT TO THE ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2023
NT PHARMA: (Revised) Next Day Disclosure Return
NT PHARMA: NEXT DAY DISCLOSURE RETURN
NT PHARMA: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
NT PHARMA: POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 28 JUNE 2024
NT PHARMA: POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 28 JUNE 2024
NT PHARMA: Notification Letter and Request Form to Registered Shareholder
NT PHARMA: Notification Letter and Request Form to Non-Registered Holder
NT PHARMA: Form of Proxy for the Extraordinary General Meeting (or at any adjournment thereof)
NT PHARMA: NOTICE OF EXTRAORDINARY GENERAL MEETING
NT PHARMA: PROPOSED SHARE CONSOLIDATION AND CHANGE IN BOARD LOT SIZE
NT PHARMA: CLARIFICATION ANNOUNCEMENT IN RELATION TO PROPOSED SHARE CONSOLIDATION AND CHANGE IN BOARD LOT SIZE
NT PHARMA: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
NT PHARMA: CHANGE OF ADDRESS OF THE PRINCIPAL PLACE OF BUSINESS AND HEADQUARTERS
NT PHARMA: PROPOSED SHARE CONSOLIDATION ANDCHANGE IN BOARD LOT SIZE
NT PHARMA: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
NT PHARMA: Notification Letter and Request Form to Non-Registered Holder
NT PHARMA: Notification Letter and Request Form to Registered Shareholder
No Data